Nurse‐led clinics for strict hypertension control are effective long term: a 7 year follow‐up study

Diabet. Med. 27, 933–937 (2010)

[1]  Rury R Holman,et al.  Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.

[2]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[3]  T. Ooi,et al.  Paradoxically Decreased HDL-Cholesterol Levels Associated with Rosiglitazone Therapy , 2006, The Annals of pharmacotherapy.

[4]  G. Gill,et al.  Successful cardiovascular risk reduction in Type 2 diabetes by nurse‐led care using an open clinical algorithm , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Diabetes Uk,et al.  JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice , 2005 .

[6]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[7]  J F Potter,et al.  Extract from : , 2009 .

[8]  S. Sheps,et al.  The Accoson Greenlight 300™, the first non-automated mercury-free blood pressure measurement device to pass the International Protocol for blood pressure measuring devices in adults , 2004, Blood pressure monitoring.

[9]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[10]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[11]  L. Poston,et al.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.

[12]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[13]  Petros Nihoyannopoulos,et al.  Joint British recommendations on prevention of coronary heart disease in clinical practice , 1998, Heart.

[14]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[15]  Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .